Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Capital Expenditures (2018 - 2026)

Updated

Moderna's Capital Expenditures was $37 million in Q2 2026, compared with $3 million a year earlier and down 40.3% from the prior quarter.

Analysis

Moderna (MRNA) Capital Expenditures (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Moderna's Capital Expenditures was $171 million through Jun 30, 2026, down 78.4% year-over-year; for FY2025, it came in at $192 million, down 81.7% from FY2024.

  • Capital Expenditures shows a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
  • In earlier years, Capital Expenditures was $1.05 billion in FY2024 (+48.7%), $707 million in FY2023 (+76.8%), $400 million in FY2022 (+40.8%) and $284 million in FY2021 (+317.6%).
  • Quarterly Capital Expenditures has moved between $3 million (Q2 2025) and $522 million (Q4 2024) over five years.
  • Compared with a year earlier, Capital Expenditures was higher in two of the last seven quarters, with an average decline of 30.2%.
  • The best year-over-year quarter for Capital Expenditures over five years was Q3 2021 (growth of 421.1%); the worst was Q2 2025 (a decline of 98.4%).
  • Per Business Quant data, MRNA's Capital Expenditures in the three quarters before Q2 2026 was $62 million (Q1 2026), $39 million (Q4 2025) and $33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 1.32 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 322.00 Mn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 1.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 140.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 533.00 Mn
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn 37.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.00 Mn
Mar 31, 2026 62.00 Mn
Dec 31, 2025 39.00 Mn
Sep 30, 2025 33.00 Mn
Jun 30, 2025 3.00 Mn
Mar 31, 2025 117.00 Mn
Dec 31, 2024 522.00 Mn
Sep 30, 2024 151.00 Mn
Jun 30, 2024 182.00 Mn
Mar 31, 2024 196.00 Mn
Dec 31, 2023 220.00 Mn
Sep 30, 2023 140.00 Mn
Jun 30, 2023 234.00 Mn
Mar 31, 2023 113.00 Mn
Dec 31, 2022 92.00 Mn
Sep 30, 2022 89.00 Mn
Jun 30, 2022 87.00 Mn
Mar 31, 2022 132.00 Mn
Dec 31, 2021 120.00 Mn
Sep 30, 2021 99.00 Mn
API Access

Moderna Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MRNA&period=max&api_key=YOUR_API_KEY